General Atlantic

General Atlantic is a global growth equity firm that specializes in making significant minority investments in growth-oriented companies. Founded in 1980 and headquartered in New York, the firm focuses on sectors such as technology, healthcare, consumer services, and financial services. With a presence in major cities across the Americas, Europe, and Asia, General Atlantic employs a collaborative approach that combines sector-specific expertise with a long-term investment horizon. The firm aims to partner with entrepreneurs and management teams to build exceptional businesses by providing both capital and strategic support. Its team of over 100 investment professionals is committed to understanding the dynamics that drive growth in various industries worldwide.

Connor Antisdale

Principal, GA Credit

Max August

Investor

Kara Barnett

Managing Director

Alexa Bartlett

Principal

Anish Batlaw

Managing Director, Portfolio Human Capital

Adam Berg

Operating Partner

Michael J. Bevan

Managing Director, BeyondNetZero Team

Sharad Bhojnagarwala

Associate

Izkandar Bloy

Vice President

Matthew Bonanno

Managing Director, GA Credit

Wilson Bowen

Principal, BeyondNetZero Team

David Buckley

Managing Director, Global Head of Growth Acceleration

Whitney Cacase

Vice President, Human Capital

Jessie Cai

Vice President

Gabriel Caillaux

Co-President, Managing Director, Head of EMEA and Head of Climate

Frederico Carvalho

Operating Principal

Rodrigo Catunda

Managing Director and Co-head of Brazil

Chris Caulkin

Managing Director and Head of Technology for EMEA

Thomas Cefalu

Analyst

Luis Cervantes

Managing Director and Head of Mexico Office

Zeev Thepris Charaf

Vice President

Laura Chen

Vice President

Alex Crisses

Managing Director, Global Head of New Investment Sourcing and Co-Head of Emerging Growth

Steven Denning

Chairman

Matthew Dorr

Principal

Michael Drittel

Vice President

Jonathan Durham

Managing Director

Jonathan Durham

Managing Director and Global Head of Technology Buyouts

Cory Eaves

Operating Partner

Martin Escobari

Co-President, Managing Director and Head of Global Growth Equity

Oscar Fan

Managing Director and Head of Consumer for China

George Fan

Managing Director and COO, GA Credit

Vince Feng

Partner

Andrew Ferrer

Managing Director

Christian Figge

Managing Director

William E. Ford

Chairman and CEO

Natasha Fowlie

Principal

Stas Futoransky

Principal, GA Credit

Roger Gao

Principal

Jon Gol

Principal, GA Credit

Aaron Goldman

Managing Director and Head of Enterprise Technology

Cornelia Gomez

Principal and Global Head of ESG and Sustainability

Michael Gosk

Managing Director and CFO

William Grabe

Managing Director

Fletcher Gregory

Principal

Sascha Guenther

Managing Director and Head of DACH

Nadia Hadi

Vice President

Rhea Hamilton

Managing Director

Asher Hecht

Principal

Robert Hedlund

Managing Director of CA Credit

David Hodgson

Vice Chairman

Ingrid van der Hoorn

Vice President, Finance

Tom Hussey

Principal

Shaw Joseph

Managing Director

Jeffrey Kaczmarski

Senior Associate

Melis Kahya

Managing Director and Head of Consumer for EMEA

Alex Kanji

Associate

Justin Kotzin

Managing Director and Head of Capital Markets

Jayden Kunwar

Analyst

John LaDien

Vice President

Peter Lafer

Principal

Samuel Lerer

Vice President

Anton Levy

Co-President, Managing Director and Chairman of Global Technology Group

Jacqueline Li

Principal

Tony Li

Principal

Victor Li Ph.D

Managing Director

Hilary Lindemann

Principal

Simon Liu

Principal

Preston McKenzie

Operating Partner

Alok Misra

Operating Partner and COO for India

Gabrielle Munoz

Associate

Raph Osnoss

Principal

Raphael Osnoss

Managing Director

Christian Osterland

Vice President

Seckin Ozdamar

Principal, Growth Acceleration Group

Armaan Pai

Vice President

Andy Papadakos

Executive Vice President

Annie Paydar

Managing Director, Member of the Executive Committee and Global Head of Human Capital

Srinivas Peddada

Principal, Investment Support Team

Gary Pesola

Investor

Jason Pitts

Principal

Nate Powell

Managing Director, GA Credit

Jordan Principe

Principal, GA Credit

Shantanu Rastogi

Managing Director

Jon Michael Reese

Vice President

Gary Reiner

Operating Partner

Maria Ribeiro

Vice President

Luiz Ribeiro

Managing Director

Graham Robertson

Principal

Jeffrey Rowbottom

Managing Director, GA Credit

Ashish Saboo

Managing Director, Chief Representative of Indonesia

Pierre Samec

Operating Partner

Ben Sherman

Vice President

Josh Smith

Managing Director and Head of GA Credit

Lefei Sun

Managing Director

Justin Sunshine

Managing Director

David Swift

Managing Director, Head of Climate and Sustainability Strategies

Tanzeen M. Syed

Managing Director and Head of Consumer Internet and Technology

Varun Talukdar

Vice President

Victor Taslim

Vice President

Philipp Thun-Hohenstein

Principal

Graves Tompkins

Managing Director, COO and Member of the Executive Committee and Investment Committee for GA Credit

John Toriello

Managing Director and Global Head of Portfolio Management and Due Diligence

Ben Tour

Vice President

Vinay Trivedi

Principal

Javier Valenzuela

Senior Associate

Anna Vershebeniuk

Senior Associate

Joanne Wang

Associate

Lu Wang

Operating Partner

Michael Whitman

President of GA Credit and Managing Director

Caroline Woodworth

Managing Director

Leo Wouters

Managing Director, Private Credit Strategy, GA Credit

Brett Zbar

Managing Director and Global Head of Life Sciences

Varun Venkat Raghavan

Senior Associate

Past deals in Boston, MA

Biofourmis

Series D in 2022
Biofourmis Singapore Pte. Ltd. is a digital therapeutics company that focuses on enhancing personalized care through innovative software-based solutions. Founded in 2015, it operates from its headquarters in Boston, Massachusetts, with additional offices in Singapore, Zurich, and Bengaluru. The company’s platform integrates artificial intelligence to analyze real-time physiological data from clinical-grade wearables, enabling healthcare professionals to detect patterns and predict medical events, such as heart failure and oncology-related issues. Its product offerings include BiovitalsHF for early heart failure detection, RhythmAnalytics for cardiac arrhythmia monitoring, and Painfocus for objective pain assessment, aimed at improving therapeutic decision-making. Additionally, Biofourmis provides Gaido for oncology patient monitoring and Biovitals Research, a digital trial platform that enhances patient engagement and data collection. Through these solutions, Biofourmis aims to facilitate better patient outcomes and cost-effective care for healthcare providers.

Panorama Education

Series C in 2021
Panorama Education is a data analytics company based in Boston, Massachusetts, focused on K-12 education. Established in 2012, the company offers a software-as-a-service platform that enables school districts, charter networks, and state governments to conduct comprehensive surveys among students, parents, teachers, and staff. The platform provides research-based surveys that generate valuable feedback on individual teachers and overall school environments. By analyzing this data, Panorama Education helps educators and administrators identify areas for improvement, addressing critical issues such as parent involvement, school safety, and student engagement. Additionally, the company offers consultation, technical assistance, and training to support the effective implementation of its tools, thereby enhancing professional development and fostering a fairer educational evaluation system.

Transmit Security

Series A in 2021
Transmit Security specializes in advanced authentication and risk management solutions for large enterprises. The company aims to enhance user experience and security while ensuring compliance with regulatory requirements, all at a reduced cost compared to traditional identity solutions. It offers a digital identity platform that features passwordless authentication through facial recognition, alongside services such as identity policy orchestration. By focusing on innovative technologies, including an app-less biometric authenticator and a low-code identity orchestration platform, Transmit Security addresses critical authentication and risk challenges across various environments, from data centers to cloud applications.

Motif

Series B in 2021
Motif FoodWorks, Inc. is a bio-organism engineering company based in Boston, Massachusetts, that specializes in developing innovative food ingredients. The company focuses on producing animal-free proteins, including meat alternatives and dairy-free proteins, catering to the growing demand for plant-based food solutions. By utilizing fermentation technology, Motif creates essential proteins and nutrients that enhance both nutrition and flavor in food products. The company collaborates with chefs, health experts, and food innovators to develop new ingredient solutions aimed at transforming the food industry and promoting sustainability. Established in 2018 and originally known as Motif Ingredients, Motif FoodWorks rebranded in 2019 to reflect its commitment to advancing the next generation of healthy and plant-based foods.

Motif

Series B in 2021
Motif FoodWorks, Inc. is a bio-organism engineering company based in Boston, Massachusetts, that specializes in developing innovative food ingredients. The company focuses on producing animal-free proteins, including meat alternatives and dairy-free proteins, catering to the growing demand for plant-based food solutions. By utilizing fermentation technology, Motif creates essential proteins and nutrients that enhance both nutrition and flavor in food products. The company collaborates with chefs, health experts, and food innovators to develop new ingredient solutions aimed at transforming the food industry and promoting sustainability. Established in 2018 and originally known as Motif Ingredients, Motif FoodWorks rebranded in 2019 to reflect its commitment to advancing the next generation of healthy and plant-based foods.

PathAI

Series C in 2021
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Allonnia

Series A in 2021
Allonnia LLC offers waste remediation services. The company engages in the development of enzymes, proteins, and microbes that degrade or metabolize contaminants and enables them to recover and upcycle valuable materials from waste and existing biological treatment processes. Allonnia LLC was incorporated in 2019 and is based in Boston, Massachusetts.

Allonnia

Series A in 2020
Allonnia LLC offers waste remediation services. The company engages in the development of enzymes, proteins, and microbes that degrade or metabolize contaminants and enables them to recover and upcycle valuable materials from waste and existing biological treatment processes. Allonnia LLC was incorporated in 2019 and is based in Boston, Massachusetts.

OutSystems

Venture Round in 2020
OutSystems, Inc. is a company that specializes in a low-code platform designed for the development of enterprise web and mobile applications. Founded in 2001 and based in Boston, Massachusetts, the platform allows organizations to build applications that can operate in cloud, on-premises, or hybrid environments. It combines low-code development with advanced capabilities, enabling users to visually develop entire applications that easily integrate with existing systems. OutSystems serves various industries, including insurance, banking, education, healthcare, and government, and targets IT leaders, enterprise architects, and professional developers. The platform is recognized for its ability to facilitate the rapid development and management of robust applications while avoiding vendor lock-in.

Ginkgo Bioworks

Series F in 2020
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Ginkgo Bioworks

Series E in 2019
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Ginkgo Bioworks

Series E in 2019
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Motif

Series A in 2019
Motif FoodWorks, Inc. is a bio-organism engineering company based in Boston, Massachusetts, that specializes in developing innovative food ingredients. The company focuses on producing animal-free proteins, including meat alternatives and dairy-free proteins, catering to the growing demand for plant-based food solutions. By utilizing fermentation technology, Motif creates essential proteins and nutrients that enhance both nutrition and flavor in food products. The company collaborates with chefs, health experts, and food innovators to develop new ingredient solutions aimed at transforming the food industry and promoting sustainability. Established in 2018 and originally known as Motif Ingredients, Motif FoodWorks rebranded in 2019 to reflect its commitment to advancing the next generation of healthy and plant-based foods.

PathAI

Series B in 2019
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

SessionM

Series E in 2018
SessionM, Inc. is a cloud-based software platform focused on customer engagement and loyalty. It provides a comprehensive marketing automation and loyalty solution that captures customer behaviors across various channels, enhancing individual profiles with real-time data. The platform features SessionM Insights, a reporting tool that analyzes the impact of loyalty programs on revenue and sales. By organizing data from point-of-sale systems, mobile applications, customer service interactions, and social media, SessionM enables businesses to understand audience behaviors and derive actionable insights. It also facilitates real-time engagement through customizable workflows that manage marketing and loyalty initiatives, including rewards and offers. The platform leverages advanced machine learning to deliver personalized customer experiences, helping brands to strengthen and optimize their relationships with consumers. Founded in 2010 and headquartered in Boston, SessionM operates globally with additional offices in major cities across the United States and Europe. As of late 2019, it functions as a subsidiary of Mastercard Incorporated.

Ginkgo Bioworks

Series D in 2017
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Ginkgo Bioworks

Series D in 2017
Ginkgo Bioworks, founded in 2008 and based in Boston, Massachusetts, specializes in biological engineering by designing, developing, and licensing custom microbes and organisms. The company focuses on discovering and producing a variety of molecules for applications in flavors, sweeteners, cosmetic ingredients, crop treatments, and pharmaceuticals. Additionally, Ginkgo Bioworks offers probiotic bacteria aimed at protecting against harmful infections and creates libraries of molecules for various uses. Its market reach includes sectors such as cultured ingredients, carbon mitigation, probiotics, and natural product discovery.

Turbonomic

Series E in 2017
Turbonomic specializes in application resource management technology that optimizes application performance, compliance, and cost in real-time. Its AI-powered platform integrates with major application performance management (APM) and IT service management solutions, creating a control plane to automate IT resource management across on-premises and multi-cloud environments. By dynamically aligning application demand with infrastructure supply, Turbonomic enables organizations to maintain optimal application health and performance while effectively managing costs. The platform's workload automation capabilities provide a comprehensive solution for hybrid cloud environments, ensuring organizations can self-manage their resources in real-time.

SessionM

Series D in 2016
SessionM, Inc. is a cloud-based software platform focused on customer engagement and loyalty. It provides a comprehensive marketing automation and loyalty solution that captures customer behaviors across various channels, enhancing individual profiles with real-time data. The platform features SessionM Insights, a reporting tool that analyzes the impact of loyalty programs on revenue and sales. By organizing data from point-of-sale systems, mobile applications, customer service interactions, and social media, SessionM enables businesses to understand audience behaviors and derive actionable insights. It also facilitates real-time engagement through customizable workflows that manage marketing and loyalty initiatives, including rewards and offers. The platform leverages advanced machine learning to deliver personalized customer experiences, helping brands to strengthen and optimize their relationships with consumers. Founded in 2010 and headquartered in Boston, SessionM operates globally with additional offices in major cities across the United States and Europe. As of late 2019, it functions as a subsidiary of Mastercard Incorporated.

New York Mercantile Exchange

Venture Round in 2005
The New York Mercantile Exchange (NYMEX) is a commodity futures exchange owned and operated by CME Group of Chicago. NYMEX is located at One North End Avenue in the World Financial Center in the Battery Park City section of Manhattan, New York City. Additional offices are located in Boston, Washington, D.C., Atlanta, San Francisco, Dubai, London, and Tokyo. Source: Wikipedia

CompuGroup Medical

Private Equity Round in 2003
CompuGroup Medical, Inc. provides software and communications solutions that assist doctors, dentists, general practitioners, clinics, rehabilitation centers and care facilities, health insurers, pharmaceutical companies, public bodies, hospitals, pharmacists, associations, networks, and other service providers with workflow, diagnosis, and therapy worldwide. It offers EHR/PM, a solution to meet the needs of physician practices and clinics or community health centers; Alteer Office, an integrated electronic healthcare record-practice management solution.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.